Ardent Health Partners, LLC (NYSE:ARDT) Receives Consensus Rating of "Buy" from Analysts

Shares of Ardent Health Partners, LLC (NYSE:ARDT - Get Free Report) have been given a consensus recommendation of "Buy" by the twelve ratings firms that are presently covering the firm, MarketBeat reports. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $21.18.

A number of research firms have issued reports on ARDT. Morgan Stanley decreased their target price on Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating for the company in a research note on Tuesday, January 21st. Royal Bank of Canada decreased their price objective on Ardent Health Partners from $23.00 to $21.00 and set an "outperform" rating for the company in a research report on Tuesday, March 4th. Truist Financial dropped their target price on shares of Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating on the stock in a report on Monday, January 6th. JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $20.00 price target on shares of Ardent Health Partners in a report on Tuesday, December 17th. Finally, Stephens reissued an "overweight" rating and set a $22.00 price objective on shares of Ardent Health Partners in a research report on Wednesday.

Institutional Trading of Ardent Health Partners

Hedge funds and other institutional investors have recently modified their holdings of the stock. Point72 Asia Singapore Pte. Ltd. bought a new position in Ardent Health Partners in the fourth quarter valued at approximately $27,000. Squarepoint Ops LLC boosted its holdings in shares of Ardent Health Partners by 1.8% in the 4th quarter. Squarepoint Ops LLC now owns 101,798 shares of the company's stock valued at $1,739,000 after buying an additional 1,798 shares during the last quarter. US Bancorp DE bought a new position in shares of Ardent Health Partners in the fourth quarter valued at $31,000. Bank of New York Mellon Corp increased its holdings in Ardent Health Partners by 8.2% during the fourth quarter. Bank of New York Mellon Corp now owns 25,615 shares of the company's stock worth $438,000 after buying an additional 1,941 shares during the last quarter. Finally, Geode Capital Management LLC raised its position in Ardent Health Partners by 1.5% during the fourth quarter. Geode Capital Management LLC now owns 142,563 shares of the company's stock worth $2,435,000 after acquiring an additional 2,127 shares in the last quarter.

Remove Ads

Ardent Health Partners Stock Up 0.1 %

NYSE ARDT traded up $0.02 on Tuesday, reaching $13.18. The company had a trading volume of 338,692 shares, compared to its average volume of 404,640. Ardent Health Partners has a 52 week low of $12.72 and a 52 week high of $20.72. The stock's 50 day moving average is $14.43 and its 200-day moving average is $16.28. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last posted its earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.31. The firm had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.48 billion. As a group, analysts predict that Ardent Health Partners will post 1.23 earnings per share for the current fiscal year.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.